Revolutionizing the production, growth, and development of stem cell and stem cell technologies.
- The staining of iPS highlighting their nuclei Green:
- A nuclear pluripotency marker Purple:
- A nuclear pluripotency marker Red:
- A cytoplasmic pluripotency marker
Providing IPS-based Platforms for Pharma & Research Institutions
StemoniX at 3D Tissue Models 2017
Request a Meeting
at 3D Tissue Models 2017
August 28 – 30
Structure Leads to Improved Cell-Based Assay Outcomes
StemoniX provides products and services for drug discovery and development. We structure human iPSC-derived cells into physiologically relevant microtissues with accelerated cell maturity that mimic the native organ tissue. Predictive, accurate, and consistent, our
human cell models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.
Structured human cardiac cells in high density screening plates to match native human heart tissue
More About microHeart
Functional human neuronal circuitry in high density screening plates to mimic human brain tissue
More About microBrain
StemoniX provides manufacturing and drug screening services and development partnerships:
Human iPS Cell Manufacturing
“Human iPS Cells From Millions to Billions”
We offer high volume, economical manufacturing platforms to expand human iPS cells with lot sizes exceeding 1 billion cells, differentiate to cardiac and neuronal cells, structure into physiologically relevant microtissues, and plate onto high throughput screening plates.
Human Neural Progenitor Cells
Discovery as a Service
Custom Assay and Disease Model Development
Leverage StemoniX expertise to develop physiologically-relevant human cell-based assays to improve your drug discovery research and screening outcomes.
Drug testing for drug discovery and high throughput screening, safety pharmacology, and investigative toxicology.
Our platforms include kinetic cellular assays with high throughput plate and multimode plate readers, high content imaging, and electrophysiology
Send us a message
We grow, differentiate, and print organ cells from skin cells, in a way that makes them biologically accurate, to better predict their toxicity and improve efficacy.
staining of fibroblasts highlighting their nuclei
staining of Actin Cytoskeleton
Our technology includes the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases.
Our team and scientific board have vetted StemoniX IP with over $200M and a track record of success
Meet the StemoniX Team
MS, MBA, PMP, PgMP, Ping has formed and led teams to producing world-changing devices. His expertise focuses on merging core intellectual property from startups to F100 corporations.
Ping Yeh | Founder & CEO
Dr. Bob Petcavich, Cofounder & Chief Science Advisor of StemoniX, is a successful serial inventor and entrepreneur, holding nearly 60 patents.
Robert Petcavich | Co-founder
PhD in cell-based assays for high throughput cancer drug discovery. A leader at the Dept. of Medicine & Division of Cardiology at University of California, San Diego.
Fabian Zanella | Head of Cell Biology
MD MBA FACEP, Dr. Khaleghi has led the personalized medicine process for WellnessFX as their medical director. He has also served as CMIO of the Noble Health System, and published 6 health books.
Murdoc Khaleghi | Chief Medical Officer
What are you interested in?
Please leave this field empty.